Identification of β‐galactosidases along the secretory pathway of <i>Nicotiana benthamiana</i> that collectively hamper engineering of galactose‐extended glycans on recombinant glycoproteins

Glycosylation is an important aspect for many biopharmaceuticals, including vaccines against parasitic helminths. Plants, especially Nicotiana benthamiana, have proven to be excellent production hosts for biopharmaceuticals with tailor-made glycosylation. If desired, galactosylation can be introduced on biopharmaceuticals through co-expression of the appropriate glycosyltransferase. However, achieving homogenous glycoforms with terminal galactose residues remains difficult as native N. benthamiana β-galactosidases (NbBGALs) truncate these glycans. Recently, the first NbBGAL has been identified, but a knockout line was insufficient to achieve near complete galactosylation, suggesting that other enzymes could have similar activity. In this study, we selected 10 NbBGALs for further investigation into subcellular localization, in vitro and in vivo activity against β1,4-linked galactose on N-glycans and β1,3-linked galactose on O-glycans. We show that NbBGAL3B is localized in the apoplast and has similar specificity for β1,4-linked galactose on N-glycans as the previously identified NbBGAL1. In contrast, none of the selected NbBGALs cleaved β1,3-linked galactose from O-glycans besides BGAL1. In addition, we provide a novel strategy to achieve near complete galactosylation on galactosidase-prone glycoproteins by using the protective capacity of the Lewis X motif and subsequent removal of the antennary fucose residues. Taken together, our results provide a broad view of the ability of NbBGALs to cleave galactoses and have identified NbBGAL3B as the second major contributor of undesired β-galactosidase activity while engineering N-glycans. This work lays the foundation for generating knockout lines that are devoid of undesired NbBGALs and therefore do not hamper the production of recombinant glycoproteins with galactose-extended glycans.

Authors

Institutions

Publication Details

Journal
Plant Biotechnology Journal
Published
2025-05-07
DOI
https://doi.org/10.1111/pbi.70126
Citations
3
Primary Topic
Transgenic Plants and Applications
Type
article
Field-Weighted Citation Impact
3.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of β‐galactosidases along the secretory pathway of Nicotiana benthamiana that collectively hamper engineering of galactose‐extended glycans on recombinant glycoproteins

Pieter Nibbering, Myrna J. M. Bunte, A. Schots, Sanaz Mokhtari et al.
3 citations
Plant Biotechnology Journal
Transgenic Plants and Applications
3.70
article

Identification of β‐galactosidases along the secretory pathway of Nicotiana benthamiana that collectively hamper engineering of galactose‐extended glycans on recombinant glycoproteins

Pieter Nibbering, Myrna J. M. Bunte, A. Schots, Sanaz Mokhtari, Ruud H. P. Wilbers, Hein Overmars, Alex van der Kaaij, Lisa Nijhof
article en
3 citations

Abstract

Glycosylation is an important aspect for many biopharmaceuticals, including vaccines against parasitic helminths. Plants, especially Nicotiana benthamiana, have proven to be excellent production hosts for biopharmaceuticals with tailor-made glycosylation. If desired, galactosylation can be introduced on biopharmaceuticals through co-expression of the appropriate glycosyltransferase. However, achieving homogenous glycoforms with terminal galactose residues remains difficult as native N. benthamiana β-galactosidases (NbBGALs) truncate these glycans. Recently, the first NbBGAL has been identified, but a knockout line was insufficient to achieve near complete galactosylation, suggesting that other enzymes could have similar activity. In this study, we selected 10 NbBGALs for further investigation into subcellular localization, in vitro and in vivo activity against β1,4-linked galactose on N-glycans and β1,3-linked galactose on O-glycans. We show that NbBGAL3B is localized in the apoplast and has similar specificity for β1,4-linked galactose on N-glycans as the previously identified NbBGAL1. In contrast, none of the selected NbBGALs cleaved β1,3-linked galactose from O-glycans besides BGAL1. In addition, we provide a novel strategy to achieve near complete galactosylation on galactosidase-prone glycoproteins by using the protective capacity of the Lewis X motif and subsequent removal of the antennary fucose residues. Taken together, our results provide a broad view of the ability of NbBGALs to cleave galactoses and have identified NbBGAL3B as the second major contributor of undesired β-galactosidase activity while engineering N-glycans. This work lays the foundation for generating knockout lines that are devoid of undesired NbBGALs and therefore do not hamper the production of recombinant glycoproteins with galactose-extended glycans.

Plant Biotechnology JournalVol. 24(1)
Wageningen University & Research (NL)
Universiteit Leiden, Universiteit Utrecht, Technische Universiteit Eindhoven, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Leids Universitair Medisch Centrum, Wageningen University and Research, Eurostars
Openalex Percentile: Top 8%
Transgenic Plants and Applications
3.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.